Intraepithelial corneal deposits associated with Mirvetuximab soravtansine use for platinum-resistant ovarian cancer
The natural reversibility of MIRV-induced keratopathies underscores the need for prompt and regular ophthalmic assessments throughout drug administration. Understanding the mechanism behind these corneal changes, how to recognize them in a clinical setting, and expedite their reversal are essential to improve quality-of-life metrics in patients receiving MIRV transfusions.
Authors
- Charlotte McRae (ORCID: https://orcid.org/0009-0009-6129-8289)
- Jack S. Parker (ORCID: https://orcid.org/0000-0002-9366-0010)
- M. I. Green
- Richard Cowan (ORCID: https://orcid.org/0000-0001-9004-8136)
Institutions
- University of Alabama at Birmingham (US)
- Vesta Sciences (United States) (US)
Publication Details
- Journal
- American Journal of Ophthalmology Case Reports
- Published
- 2025-02-05
- DOI
- https://doi.org/10.1016/j.ajoc.2025.102271
- Citations
- 1
- Primary Topic
- Ovarian cancer diagnosis and treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.70